| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.03 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |